Software Healthcare Sector

AdaptHealth

Market Cap: US$1.1b

Distributes home medical equipment (HME), medical supplies, and home and related services in the United States.

Dynavax Technologies

Market Cap: US$1.1b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Natus Medical

Market Cap: US$1.1b

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.

U.S. Physical Therapy

Market Cap: US$1.1b

Operates and manages outpatient physical therapy clinics.

Ocular Therapeutix

Market Cap: US$1.1b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

89bio

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.

BioLife Solutions

Market Cap: US$1.1b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Aurinia Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

Spire Healthcare Group

Market Cap: UK£818.8m

Owns and operates private hospitals and clinics in the United Kingdom.

10x Genomics

Market Cap: US$1.1b

A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

BGM Group

Market Cap: US$1.1b

Through its subsidiaries, operates as a pharmaceutical and chemical company in China.

Neuren Pharmaceuticals

Market Cap: AU$1.7b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Aveanna Healthcare Holdings

Market Cap: US$1.1b

A diversified home care platform company, provides pediatric and adult healthcare services in the United States.

Evolent Health

Market Cap: US$1.0b

Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.

MiMedx Group

Market Cap: US$1.0b

Develops and distributes placental tissue allografts for various sectors of healthcare.

NeoGenomics

Market Cap: US$1.0b

Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.

Nika Pharmaceuticals

Market Cap: US$1.0b

Engages in the development and distribution of various pharmaceutical products.

Wave Life Sciences

Market Cap: US$1.0b

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

Viridian Therapeutics

Market Cap: US$1.0b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Pennant Group

Market Cap: US$985.1m

Provides healthcare services in the United States.

Oculis Holding

Market Cap: US$983.7m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

OPKO Health

Market Cap: US$983.4m

A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

InMode

Market Cap: US$980.7m

Designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.

Establishment Labs Holdings

Market Cap: US$980.6m

A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

Novavax

Market Cap: US$967.8m

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

STAAR Surgical

Market Cap: US$961.5m

Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

Integra LifeSciences Holdings

Market Cap: US$952.0m

Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

Mineralys Therapeutics

Market Cap: US$950.4m

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

Nanosonics

Market Cap: AU$1.5b

Operates as an infection prevention company globally.

Collegium Pharmaceutical

Market Cap: US$928.6m

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Pharvaris

Market Cap: US$925.8m

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Syndax Pharmaceuticals

Market Cap: US$920.7m

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

Phibro Animal Health

Market Cap: US$910.8m

Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.

Avadel Pharmaceuticals

Market Cap: US$908.4m

Operates as a biopharmaceutical company in the United States.

Enliven Therapeutics

Market Cap: US$903.8m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

Harrow

Market Cap: US$895.5m

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.